Page last updated: 2024-08-25

suplatast tosilate and Hepatitis C, Chronic

suplatast tosilate has been researched along with Hepatitis C, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inada, M; Maeda, H; Matsuda, Y; Matsuyama, T	1

Trials

1 trial(s) available for suplatast tosilate and Hepatitis C, Chronic

Article	Year
Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease. Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:10 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Arylsulfonates; Cholagogues and Choleretics; Cytokines; D-Alanine Transaminase; Drug Resistance; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Function Tests; Male; Middle Aged; Safety; Sulfonium Compounds; Th2 Cells; Treatment Outcome; Ursodeoxycholic Acid	2002

Article

Year

Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease.

Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:10

Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Arylsulfonates; Cholagogues and Choleretics; Cytokines; D-Alanine Transaminase; Drug Resistance; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Function Tests; Male; Middle Aged; Safety; Sulfonium Compounds; Th2 Cells; Treatment Outcome; Ursodeoxycholic Acid

2002